Table 273: IVAX Diagnostics Amends Its Distribution Agreement With IMMCO Diagnostics 414 Table 274: IVAX Diagnostics Signs Distribution Agreement With Augurix 415 Table 275: Prodesse Enters Into A licensing Agreement With Abbott Laboratories 416 Table 276: USD to Local Currency, Average Exchange Rate 2008 466 1.2 List of Figures Figure 1: In Vitro Diagnostics, Global, Overall Revenue ($m), Historic, 2000-2008 35 Figure 2: In Vitro Diagnostics, Global, Overall Revenue ($m), Forecast, 2008-2015 37 Figure 3: In Vitro Diagnostics, Global, Cross-Category Analysis, 2000-2015 41 Figure 4: In Vitro Diagnostics, Global, Company share (%), 2008 43 Figure 5: In Vitro Diagnostics, Market Attractiveness Analysis, By Category, 2008 – 2015 45 Figure 6: In Vitro Diagnostics, Cross Country Comparison, Revenue ($m), 2000-2015 47 Figure 7: In Vitro Diagnostics, US, Overall Revenue ($m), Historic, 2000-2008 49 Figure 8: In Vitro Diagnostics, US, Overall Revenue ($m), Forecast, 2008-2015 51 Figure 9: In Vitro Diagnostics, US, Cross-Category Analysis, 2000-2015 53 Figure 10: In Vitro Diagnostics, US, Company Share (%), 2008 59 Figure 11: Clinical Chemistry, US, Company Share (%), 2008 61 Figure 12: Genetic Testing, US, Company Share (%), 2008 63 Figure 13: Haematology, US, Company Share (%), 2008 65 Figure 14: Histology And Cytology, US, Company Share (%), 2008 66 Figure 15: Immuno Chemistry, US, Company Share (%), 2008 67 Figure 16: Infectious Immunology, US, Company Share (%), 2008 69 Figure 17: Microbiology Culture, US, Company Share (%), 2008 71 Figure 18: In Vitro Diagnostics, Japan, Overall Revenue ($m), Historic, 2000-2008 72 Figure 19: In Vitro Diagnostics, Japan, Overall Revenue ($m), Forecast, 2008-2015 74 Figure 20: In Vitro Diagnostics, Japan, Cross-Category Analysis, 2000-2015 76 Figure 21: In Vitro Diagnostics, Japan, Company Share (%), 2008 82 Figure 22: Clinical Chemistry, Japan, Company Share (%), 2008 84 Figure 23: Genetic Testing, Japan, Company Share (%), 2008 86 Figure 24: Haematology, Japan, Company Share (%), 2008 88 Figure 25: Histology And Cytology, Japan, Company Share (%), 2008 90 Figure 26: Immuno Chemistry, Japan, Company Share (%), 2008 92 Figure 27: Infectious Immunology, Japan, Company Share (%), 2008 94 Figure 28: Microbiology Culture, Japan, Company Share (%), 2008 96 Figure 29: In Vitro Diagnostics, Germany, Overall Revenue ($m), Historic, 2000-2008 98 Figure 30: In Vitro Diagnostics, Germany, Overall Revenue ($m), Forecast, 2008-2015 100 Figure 31: In Vitro Diagnostics, Germany, Cross-Category Analysis, 2000-2015 102 Figure 32: In Vitro Diagnostics, Germany, Company Share (%), 2008 108 Figure 33: Clinical Chemistry, Germany, Company Share (%), 2008 110 Figure 34: Genetic Testing, Germany, Company Share (%), 2008 112 Figure 35: Haematology, Germany, Company Share (%), 2008 113 Figure 36: Histology And Cytology, Germany, Company Share (%), 2008 115 Figure 37: Immuno Chemistry, Germany, Company Share (%), 2008 117 Figure 38: Infectious Immunology, Germany, Company Share (%), 2008 119 Figure 39: Microbiology Culture, Germany, Company Share (%), 2008 121 Figure 40: In Vitro Diagnostics, Italy, Overall Revenue ($m), Historic, 2000-2008 123 Figure 41: In Vitro Diagnostics, Italy, Overall Revenue ($m), Forecast, 2008-2015 125 Figure 42: In Vitro Diagnostics, Italy, Cross-Category Analysis, 2000-2015 127 Figure 43: In Vitro Diagnostics, Italy, Company Share (%), 2008 133(Editor in charge ：Roy Huang) |